NgoMashi 12th 2022, iI-NMPA (I-SFDA) ukhiphe isaziso esigunyaza ukushintshwa kwesicelo sokuzihlola kwemikhiqizo ye-COVID-19 antigen nguNanjing Vazyme BiotechCo., Ltd, Beijing Jinwofu Bioengineering TechnologyCo., Ltd, I-Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, I-Guangzhou Wondfo Biotech Co., Ltd futhiBI-eijing Savant Biotechnology Co., Ltd(Huakeitha). Imikhiqizo emihlanu yokuzihlolela i-COVID-19 antigen yethuliwe.
Mhla ziyi-11 kuNdasa wezi-2022, i-NHC yamemezela ukuthi, ukuze kuqhutshekwe nokuthuthukiswa kwesu lokuhlola i-Novel Coronavirus futhi kufezeke izidingo zokuvikela nokulawula i-COVID-19, Ithimba Eliphelele Lendlela Yokubambisana Yokuvimbela nokulawula yoMkhandlu Wombuso yanquma ukwengeza ukuhlolwa kwe-antigen ekuhlolweni kwe-nucleic acid futhi kwenziwa“I-Application Protocol for Novel Coronavirus Antigen Detection (Trial)”
Iphrothokholi icacisa inani labantu elisebenzayo ekuhlolweni kwe-antigen:
Okokuqala, labo abavakashela izikhungo zezokwelapha eziyinhloko futhi babe nezimpawu ezifana nepheshana lokuphefumula kanye nomkhuhlane phakathi kwezinsuku ezingu-5 zokuqala kwezimpawu;
Okwesibili, izisebenzi ezibheka ukuvalelwa kwabantu bodwa, okuhlanganisa ukubhekwa kwezindawo zokuhlala zodwa, ukuthintana eduze kanye nokuxhumana okuseduze, ukubhekwa kokuvalelwa kwabantu abangenayo, indawo yokugcina izinto kanye nabasebenzi bendawo yokulawula;
Okwesithathu yizakhamuzi zomphakathi ezinesidingo sokuzihlola kwe-antigen.
Amathiphu:Ukutholwa kwe-antigen kuyisithasiselo esibalulekile sokutholwa kwe-nucleic acid, kodwa imiphumela yokuzibona i-antigen ayikwazi ukusetshenziswa njengesisekelo sokuxilonga ukutheleleka.
Isikhathi sokuthumela: Mar-22-2022